Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Atrayees on 2023-6-27

Curated date: 2021/01/10

Curator: Michael Lutete

Revision editor(s): Claregrieve1, WikiWorks, Atrayees

Source: Text, Figure S3

Description: Bacterial species from stool samples that differ between HIV-positive ART-treated Zimbabwean children randomized to continue versus stop cotrimoxazole prophylaxis based on protein families

Abundance in Group 1: decreased abundance in continue cotrimoxazole prophylaxis

NCBI	Quality Control	Links
Haemophilus parainfluenzae
Holdemanella biformis
Streptococcus parasanguinis
Faecalibacterium prausnitzii
Streptococcus salivarius
Alistipes onderdonkii
Intestinibacter bartlettii
Eggerthella lenta
Streptococcus mutans
Streptococcus vestibularis

Revision editor(s): Claregrieve1, WikiWorks, Atrayees